ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Ŭ¸®´Ð ¾È³»
Ŭ¸®´ÐÀ» ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Ŭ¸®´ÐÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
°©»ó¼±Å¬¸®´Ð
-
[±¹¿Ü³í¹®]
Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease
Seo JA, Kim NH, Park SY, Kim HY, Ryu OH, Lee KW, Lee J, Kim DJ, Choi KM, Baik SH, Choi DS, Kim SG.
/ Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease
/ 200804
-
[±¹¿Ü³í¹®]
Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease
Choi KM, Lee JS, Kim EJ, Baik SH, Seo HS, Choi DS, Oh DJ, Park CG.
/ Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease
/ 200802
-
[±¹¿Ü³í¹®]
Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness
Choi KM, Yoo HJ, Kim HY, Lee KW, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH.
/ Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness
/ 200801
-
[±¹¿Ü³í¹®]
PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty acid metabolic enzymes
Seo YS, Kim JH, Jo NY, Choi KM, Baik SH, Park JJ, Kim JS, Byun KS, Bak YT, Lee CH, Kim AR, Yeon JE.
/ PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty acid metabolic enzymes
/ 200801
-
[±¹¿Ü³í¹®]
Expression of oncostatin M in chronic obstructive sialadenitis of the submandibular gland
Lee HM, Cho JG, Kang HJ, Chae SW, Hwang SJ, Jung KY. Woo JS
/ Expression of oncostatin M in chronic obstructive sialadenitis of the submandibular gland
/ 200801